Infigratinib in Subjects With GC or GEJ With FGFR2 Amplification or Other Solid Tumors With Other FGFR Alterations

Name: Infigratinib in Subjects With GC or GEJ With FGFR2 Amplification or Other Solid Tumors With Other FGFR Alterations
Published: 2020
License: Public Domain

LianBio LLC · 2020

ClinicalTrials.gov · Datasets · License: Public Domain · 2020

Open Source ↗

gastric-cancer receptors

gastric cancer, gastroesophageal junction adenocarcinoma, solid tumor, receptors, fibroblast growth factor, gastroesophageal junction, interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Infigratinib in Subjects With GC or GEJ With FGFR2 Amplification or Other Solid Tumors With Other FGFR Alterations

Related documents